SWOG clinical trial number
SWOG-7208
5-Azacitidine (NSC-102816) Intravenously on five consecutive days every 3 weeks in Adults with Solid Tumors and Lymphomas
Closed
Abbreviated Title
5-Azacitidine (NSC-102816) Intravenously on five consecutive days every 3 weeks in Adults with Solid Tumors and Lymphomas
Activated
08/07/1972
Closed
10/16/1973
Publication Information Expand/Collapse
1978
Phase II study of 5-azacytidine in solid tumors.
1977
Phase II study of 5-azacytidine in solid tumors.
1974
A phase II study of 5-azacytidine (5-azaC) in the treatment of solid tumors.